| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/25/2022 | 435.71% | Alliance Global Partners | → $15 | Initiates Coverage On | → Buy |
| 08/23/2022 | 114.29% | Truist Securities | $10 → $6 | Maintains | Hold |
| 06/22/2022 | 435.71% | HC Wainwright & Co. | → $15 | Initiates Coverage On | → Buy |
| 04/06/2022 | — | Truist Securities | Downgrades | Buy → Hold | |
| 01/28/2022 | 221.43% | Oppenheimer | → $9 | Initiates Coverage On | → Outperform |
| 11/24/2021 | 221.43% | Morgan Stanley | → $9 | Initiates Coverage On | → Equal-Weight |
| 10/19/2021 | 328.57% | Truist Securities | → $12 | Initiates Coverage On | → Buy |
Celularity Questions & Answers
The latest price target for Celularity (NASDAQ: CELU) was reported by Alliance Global Partners on August 25, 2022. The analyst firm set a price target for $15.00 expecting CELU to rise to within 12 months (a possible 435.71% upside). 7 analyst firms have reported ratings in the last year.
The latest analyst rating for Celularity (NASDAQ: CELU) was provided by Alliance Global Partners, and Celularity initiated their buy rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Celularity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Celularity was filed on August 25, 2022 so you should expect the next rating to be made available sometime around August 25, 2023.
While ratings are subjective and will change, the latest Celularity (CELU) rating was a initiated with a price target of $0.00 to $15.00. The current price Celularity (CELU) is trading at is $2.80, which is within the analyst's predicted range.
